Ligand Pharmaceuticals (LGND) Stock: Buy, Sell, or Hold?
$316.27
-0.56 (-0.18%)
▼
5d:
+5.78%
30d:
+7.21%
90d:
+7.36%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (68%)
Quality Score
55/100
Position
EXTENDED
30-Day Fair Range
$298.92 – $315.52
Position: EXTENDED
Forward P/E & Valuation
26.5x
FAIR
vs 23.3x historical avg
Wall Street Target
$361.27
+14.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$297.63 / $325.96
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: LGND shows positive signals but monitor for confirmation. Market pricing in 4.4% annual growth which appears achievable. Moderate conviction.
Get Alerted When LGND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$540.16
Based on 14.4% avg growth
INTRINSIC VALUE TODAY
$335.39
5.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LGND is currently trading at $316.27, which is considered extended relative to its 30-day fair value range of $298.92 to $315.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.5) compared to its historical average (23.3). At these levels, the market is pricing in 4.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LGND is showing sideways momentum. Immediate support is located at $297.63, while resistance sits at $325.96.
Market Sentiment: LGND scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $361.27 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LGND is showing sideways momentum. Immediate support is located at $297.63, while resistance sits at $325.96.
Market Sentiment: LGND scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $361.27 (+14.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$298.92 -
$315.52
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.1%
Trading Range & Key Levels
30-Day Trading Range
$298.92 -
$315.52
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$16.60
(5.2%)
Support Level
$297.63
Resistance Level
$325.96
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($361.27)
- NEUTRAL: Market pricing in 4.4% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
26.46
Wall Street Target
$361.27
(+14.2%)
Revenue Growth (YoY)
-31.8%
Earnings Growth (YoY)
825.0%
Profit Margin
20.3%
Valuation Premium vs History
+4.4% premium
PE vs Historical
26.5 vs 23.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$330.19
(+4%)
2-Year Target
$344.71
(+9%)
3-Year Target
$359.88
(+14%)
3-Yr Target (if PE normalizes)
(PE: 26→23)
PE COMPRESSION
$316.95
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.5, Growth: 24.8%)
$614.27
(+94%)
Base:
(SPY PE: 19.9, Growth: 24.8%)
$461.13
(+46%)
Bear:
(PE: 16.9, Growth: 24.8%)
$391.96
(+24%)
📈
Valuation based on Current Earnings
Forward PE: 25.45 | Forward EPS (Implied): $12.43
Bull Case
$381.90
(+21%)
Analyst growth 15.0%, PE expands to 26.7
Base Case
$316.27
(0%)
Market implied 0.0%, PE stable at 25.5
Bear Case
$241.95
(-24%)
Severe decline -15.0%, PE contracts to 22.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share LGND Analysis
Share this live LGND analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LGND)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment towards $LGND, anticipating a surge in volume and potential price increase.
Key Retail Themes:
Volume surge
Price increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:32 AM ET
Data refreshes hourly during market hours. Next update: 4:32 AM
Data refreshes hourly during market hours. Next update: 4:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Advanced LGND Option Strategies
Professional options setups generated by AI based on today's LGND price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LGND Research Pages
